Related Experiment Video
Updated: Jun 10, 2025

04:23
The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
Published on: February 21, 2025
245
Late-onset primary muscle diseases mimicking sarcopenia
1Department of Neurology, International University of Health and Welfare Narita Hospital, Narita, Japan.
Geriatrics & Gerontology International
|October 15, 2024
Summary
Sarcopenia and late-onset myopathies share overlapping symptoms, complicating diagnosis in older adults. This review clarifies diagnostic criteria and algorithms to distinguish these distinct muscle conditions.
Area of Science:
- Geriatric Medicine
- Neurology
- Muscle Physiology
Background:
- Sarcopenia, an age-related loss of muscle mass and function, and late-onset primary myopathies present overlapping symptoms.
- Differentiating these conditions is crucial for appropriate management in the elderly population.
Purpose of the Study:
- To review the evolution of sarcopenia diagnostic criteria.
- To outline late-onset primary myopathies that mimic sarcopenia.
- To provide diagnostic algorithms for differentiating these muscle disorders.
Main Methods:
- Literature review of diagnostic criteria for sarcopenia.
- Analysis of common pathogenic mechanisms between sarcopenia and myopathies.
- Examination of diagnostic approaches for late-onset myopathies.
Main Results:
- Diagnostic criteria for sarcopenia have evolved, with various expert proposals.
- Late-onset myopathies (e.g., inclusion body myositis, muscular dystrophies) share mechanisms with sarcopenia.
- Clinical evaluation, history, physical exam, and testing are vital for diagnosis.
Conclusions:
- Accurate differentiation between sarcopenia and primary myopathies is essential for tailored treatment.
- Understanding shared pathomechanisms aids in diagnosis.
- This review offers guidance for clinical evaluation and diagnostic algorithms.
Related Concept Videos
Disorders of the Skeletal Muscle
900
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
900
Cross-bridge Cycle
117.0K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
117.0K
Satellite Stem Cells and Muscular Dystrophy
1.9K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
1.9K
Parkinson's Disease: Overview
487
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
487
Myasthenia Gravis: Overview and Treatment
1.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K
Myasthenia Gravis: Diagnostic Tests
686
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
686

